+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Smoking Cessation & Nicotine De-Addiction Product Market - Global Forecast to 2030- Product Image
Smoking Cessation & Nicotine De-Addiction Product Market - Global Forecast to 2030- Product Image
Sale

Smoking Cessation & Nicotine De-Addiction Product Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968933
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Smoking Cessation & Nicotine De-Addiction Product Market grew from USD 30.89 billion in 2024 to USD 34.01 billion in 2025. It is expected to continue growing at a CAGR of 9.72%, reaching USD 53.93 billion by 2030.

Smoking remains a leading cause of preventable disease worldwide, driving demand for effective cessation and de-addiction solutions. In response, the market has evolved from traditional nicotine replacement therapies to integrated, patient-centric approaches that combine pharmacological, behavioral and alternative methods. Stakeholders-including clinicians, homecare providers and rehabilitation centers-are increasingly focused on personalized interventions to improve quit rates and long-term abstinence. While regulatory agencies tighten guidelines and public awareness campaigns intensify, manufacturers and service providers seek to differentiate through innovative delivery formats, digital support tools and holistic treatment pathways. This introduction sets the stage for an executive summary that examines landmark shifts, policy impacts, segmentation dynamics, regional performance and competitive strategies shaping the future of smoking cessation and nicotine de-addiction.

Transformative Shifts Shaping Treatment Effectiveness and Patient Engagement

Over the past decade, the smoking cessation landscape has undergone transformative shifts driven by technological breakthroughs and evolving consumer preferences. Digital therapeutics and mobile health platforms now enable real-time monitoring of cravings and personalized coaching, complementing traditional nicotine replacement formats. Moreover, regulatory bodies have approved novel pharmacotherapies with enhanced safety profiles, incentivizing investment in research and development. Consumer demand has shifted toward discreet, portable delivery systems-patches, inhalers and lozenges-that integrate seamlessly into daily routines. At the same time, the rise of non-nicotine alternatives such as herbal supplements and hypnotherapy highlights a growing interest in holistic wellness. As public health campaigns underscore the risks of long-term nicotine dependence, collaborative models involving clinics, hospitals and rehabilitation centers are gaining traction. Collectively, these developments are redefining competitive dynamics, accelerating market consolidation and raising the bar for product efficacy and user engagement.

Cumulative Impact of United States Tariffs on Cost Structures and Supply Chains

In 2025, new United States tariffs on imported nicotine replacement components and devices have exerted significant pressure on cost structures across the value chain. Manufacturers relying on overseas suppliers for critical ingredients like gum bases, patch adhesives and inhaler cartridges now face elevated production expenses. These cost increases are expected to cascade through distribution channels, potentially prompting higher retail prices and squeezing margins for pharmacy stores, supermarkets and online platforms. In response, several domestic producers have accelerated plans to localize manufacturing of lozenges, nasal sprays and patch liners, supported by government incentives for reshoring strategic industries. Furthermore, industry leaders are exploring vertically integrated models that combine formulation, packaging and distribution under one roof to mitigate future tariff exposure. As a result of these policy changes, stakeholders are compelled to optimize supply chains, renegotiate supplier agreements and innovate more cost-effective delivery formats without compromising therapeutic efficacy.

Key Segmentation Insights Across Products, End Users, Channels and Demographics

A granular view of market segmentation reveals diverse pathways to address nicotine dependence. Examining product types shows that nicotine replacement therapy (NRT) continues to anchor treatment regimens, spanning gum, inhalers, lozenges, nasal sprays and patches, while non-nicotine approaches such as herbal supplements complement prescription drugs-bupropion and varenicline-offering tailored pharmacological support. End-user analysis underscores the importance of setting-specific strategies: clinics and hospitals leverage structured programs, whereas homecare settings and rehabilitation centers prioritize convenience and patient autonomy. Distribution channels diverge between offline sales through pharmacy stores, retail outlets and supermarkets & hypermarkets, and rapidly expanding online platforms that deliver subscription-based support. Demographic insights highlight that adults, seniors and even youth-aged teenagers seek solutions calibrated to gender differences-female and male smokers-and varying smoking intensity, from light to moderate to heavy usage. Patterns of usage frequency further differentiate first-time users experimenting with cessation aids from intermittent quitters and regular users committed to sustained therapy. Therapeutic approach segmentation spans alternative modalities-acupuncture and hypnotherapy-behavioral therapy and pharmacotherapy, each addressing physiological, psychological and social facets of addiction. Packaging choices, including bulk formats, combo packs and single-dose offerings, cater to budget-conscious consumers and those prioritizing portability or adherence tracking.

Key Regional Insights Highlighting Market Drivers and Challenges

Regional performance varies significantly, reflecting local regulations, healthcare infrastructure and cultural attitudes. In the Americas, robust R&D ecosystems and favorable reimbursement policies have established the region as a hub for both product innovation and digital cessation platforms. Consumer awareness remains high, driving uptake of patches, inhalers and online counseling services. Across Europe, Middle East & Africa, the market is fragmented by diverse regulatory frameworks and reimbursement schemes; established markets in Western Europe are characterized by stringent safety and efficacy requirements, while emerging territories in Africa seek cost-effective, low-barrier interventions. In the Middle East, rising investments in public health initiatives are expanding access to behavioral therapies and alternative approaches. Meanwhile, Asia-Pacific is witnessing rapid adoption fueled by high smoking prevalence in certain markets, growing middle-class purchasing power and government-led anti-smoking campaigns. Local players in India, China and Southeast Asia are collaborating with global firms to develop culturally adapted cessation programs and affordable packaging formats.

Key Company Insights from Global Giants to Niche Innovators

The competitive landscape features a mix of global tobacco giants, multinational pharmaceutical conglomerates and specialized de-addiction innovators. Leading tobacco firms like British American Tobacco PLC, Philip Morris International Inc. and Japan Tobacco Inc. leverage extensive distribution networks to introduce next-generation nicotine products. Pharmaceuticals heavyweights such as Pfizer Inc., Johnson & Johnson, Novartis International AG and GlaxoSmithKline PLC focus on clinical-grade therapies and digital adherence platforms. Innovative biotechnology and therapeutic entrants, including 22nd Century Group, Inc., Alkalon A/S and Axsome Therapeutics, Inc., are pioneering disruptive formulations and targeted receptor modulators. Regional champions like Cipla Ltd., Dr. Reddy’s Laboratories Limited, Glenmark Pharmaceuticals Limited, Sparsha Pharma International Pvt. Ltd. and Strides Pharma Science Limited drive affordability in emerging markets. Meanwhile, players such as Ditch Labs, Enorama Pharma AB and Itaconix explore novel delivery vectors, and consumer-focused brands like JUUL Labs, Inc., Perrigo Company PLC and Pierre Fabre S.A. prioritize user experience and branding. Smaller but nimble outfits-Rusan Pharma Ltd., Samyang Holdings Corporation and others-are carving niches with specialized packaging, combination therapies and alternative modalities. In this dynamic environment, strategic alliances, licensing agreements and co-development partnerships are essential to secure market share and accelerate time to market.

Actionable Recommendations for Industry Leaders to Drive Growth and Resilience

To capitalize on evolving opportunities, industry leaders should adopt a multifaceted strategy that balances innovation with operational resilience. First, integrating digital health solutions into core product offerings will enhance patient engagement and provide actionable adherence data. Second, diversifying supply chains and localizing critical manufacturing processes can mitigate tariff and geopolitical risks. Third, segment-specific product customization-tailoring dosage forms and packaging for distinct age groups, smoking intensities and usage patterns-will unlock new revenue streams. Fourth, forging partnerships with clinics, homecare providers and rehabilitation centers can facilitate seamless end-to-end care pathways. Fifth, expanding presence in high-growth emerging markets through strategic alliances and licensing can offset stagnation in mature regions. Finally, prioritizing compliance with tightening regulatory standards and obtaining early regulatory approvals for novel therapies will secure first-mover advantages and build stakeholder trust.

Conclusion Emphasizing Agility, Collaboration and Patient Outcomes

In conclusion, the smoking cessation and nicotine de-addiction market stands at the intersection of technological innovation, regulatory evolution and shifting consumer behaviors. Transformative advances in digital therapeutics, emerging non-nicotine modalities and strategic supply chain realignments are redefining competitive boundaries. Detailed segmentation analysis underscores the necessity of omnichannel distribution, demographic-specific product design and adaptive therapeutic approaches. Regional insights reveal both opportunities in high-prevalence markets and challenges in regulatory fragmentation. As companies navigate tariff-induced cost pressures and intensifying competition, success will hinge on agility, collaboration and relentless focus on patient outcomes. By embracing these principles, stakeholders can drive meaningful impact in global efforts to reduce tobacco-related harm and support sustained cessation.

Market Segmentation & Coverage

This research report categorizes the Smoking Cessation & Nicotine De-Addiction Product Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Nicotine Replacement Therapy (NRT)
    • Gum
    • Inhalers
    • Lozenges
    • Nasal Sprays
    • Patches
  • Non-Nicotine Therapy
    • Herbal Supplements
    • Prescription Drugs
      • Bupropion
      • Varenicline
  • Clinics
  • Homecare Settings
  • Hospitals
  • Rehabilitation Centers
  • Offline Sales
    • Pharmacy Stores
    • Retail Stores
    • Supermarkets & Hypermarkets
  • Online Sales
  • Age Group
    • Adults
    • Seniors
    • Teenagers
  • Gender
    • Female
    • Male
  • Smoking Intensity
    • Heavy Smokers
    • Light Smokers
    • Moderate Smokers
  • First-Time Users
  • Intermittent Users
  • Regular Users
  • Alternative Therapies
    • Acupuncture
    • Hypnotherapy
  • Behavioral Therapy
  • Pharmacotherapy
  • Bulk Packaging
  • Combo Packs
  • Single Dose

This research report categorizes the Smoking Cessation & Nicotine De-Addiction Product Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Smoking Cessation & Nicotine De-Addiction Product Market to delves into recent significant developments and analyze trends in each of the following companies:

  • 22nd Century Group, Inc.
  • Alkalon A/S
  • Axsome Therapeutics, Inc.
  • British American Tobacco PLC
  • Cipla Ltd.
  • Ditch Labs
  • Dr. Reddy’s Laboratories Limited
  • Enorama Pharma AB
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Imperial Tobacco Company of India Limited
  • Itaconix
  • Japan Tobacco Inc.
  • Johnson & Johnson
  • JUUL Labs, Inc.
  • Novartis International AG
  • Perrigo Company PLC
  • Pfizer Inc.
  • Philip Morris International Inc.
  • Pierre Fabre S.A.
  • Rusan Pharma Ltd.
  • Samyang Holdings Corporation
  • Sparsha Pharma International Pvt. Ltd.
  • Strides Pharma Science Limited

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Smoking Cessation & Nicotine De-Addiction Product Market, by Product Type
8.1. Introduction
8.2. Nicotine Replacement Therapy (NRT)
8.2.1. Gum
8.2.2. Inhalers
8.2.3. Lozenges
8.2.4. Nasal Sprays
8.2.5. Patches
8.3. Non-Nicotine Therapy
8.3.1. Herbal Supplements
8.3.2. Prescription Drugs
8.3.2.1. Bupropion
8.3.2.2. Varenicline
9. Smoking Cessation & Nicotine De-Addiction Product Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Homecare Settings
9.4. Hospitals
9.5. Rehabilitation Centers
10. Smoking Cessation & Nicotine De-Addiction Product Market, by Distribution Channel
10.1. Introduction
10.2. Offline Sales
10.2.1. Pharmacy Stores
10.2.2. Retail Stores
10.2.3. Supermarkets & Hypermarkets
10.3. Online Sales
11. Smoking Cessation & Nicotine De-Addiction Product Market, by Target Demographics
11.1. Introduction
11.2. Age Group
11.2.1. Adults
11.2.2. Seniors
11.2.3. Teenagers
11.3. Gender
11.3.1. Female
11.3.2. Male
11.4. Smoking Intensity
11.4.1. Heavy Smokers
11.4.2. Light Smokers
11.4.3. Moderate Smokers
12. Smoking Cessation & Nicotine De-Addiction Product Market, by Usage Frequency
12.1. Introduction
12.2. First-Time Users
12.3. Intermittent Users
12.4. Regular Users
13. Smoking Cessation & Nicotine De-Addiction Product Market, by Therapeutic Approach
13.1. Introduction
13.2. Alternative Therapies
13.2.1. Acupuncture
13.2.2. Hypnotherapy
13.3. Behavioral Therapy
13.4. Pharmacotherapy
14. Smoking Cessation & Nicotine De-Addiction Product Market, by Packaging Type
14.1. Introduction
14.2. Bulk Packaging
14.3. Combo Packs
14.4. Single Dose
15. Americas Smoking Cessation & Nicotine De-Addiction Product Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Smoking Cessation & Nicotine De-Addiction Product Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Smoking Cessation & Nicotine De-Addiction Product Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. 22nd Century Group, Inc.
18.3.2. Alkalon A/S
18.3.3. Axsome Therapeutics, Inc.
18.3.4. British American Tobacco PLC
18.3.5. Cipla Ltd.
18.3.6. Ditch Labs
18.3.7. Dr. Reddy’s Laboratories Limited
18.3.8. Enorama Pharma AB
18.3.9. GlaxoSmithKline PLC
18.3.10. Glenmark Pharmaceuticals Limited
18.3.11. Imperial Tobacco Company of India Limited
18.3.12. Itaconix
18.3.13. Japan Tobacco Inc.
18.3.14. Johnson & Johnson
18.3.15. JUUL Labs, Inc.
18.3.16. Novartis International AG
18.3.17. Perrigo Company PLC
18.3.18. Pfizer Inc.
18.3.19. Philip Morris International Inc.
18.3.20. Pierre Fabre S.A.
18.3.21. Rusan Pharma Ltd.
18.3.22. Samyang Holdings Corporation
18.3.23. Sparsha Pharma International Pvt. Ltd.
18.3.24. Strides Pharma Science Limited
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET MULTI-CURRENCY
FIGURE 2. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET MULTI-LANGUAGE
FIGURE 3. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY LOZENGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NASAL SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HERBAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BUPROPION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY VARENICLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PHARMACY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SENIORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TEENAGERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HEAVY SMOKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY LIGHT SMOKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY MODERATE SMOKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY FIRST-TIME USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INTERMITTENT USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY REGULAR USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HYPNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BULK PACKAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COMBO PACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 96. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 109. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 111. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 112. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 113. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 116. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 117. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 118. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 119. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 120. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 121. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 122. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 123. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 126. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 127. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 131. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 132. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 133. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 134. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 135. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 136. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 137. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 138. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 171. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 186. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 188. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 189. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 190. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 193. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 194. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 195. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 196. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 197. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 198. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 199. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 200. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 201. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 203. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 204. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 205. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 208. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 209. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 210. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 211. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 212. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 213. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 214. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 215. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 216. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 218. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 231. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 233. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 234. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 235. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 238. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 239. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 240. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 241. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 242. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 243. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 244. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
TABLE 245. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 246. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY (NRT), 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NON-NICOTINE THERAPY, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OFFLINE SALES, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TARGET DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SMOKING INTENSITY, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA

Companies Mentioned

  • 22nd Century Group, Inc.
  • Alkalon A/S
  • Axsome Therapeutics, Inc.
  • British American Tobacco PLC
  • Cipla Ltd.
  • Ditch Labs
  • Dr. Reddy’s Laboratories Limited
  • Enorama Pharma AB
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Imperial Tobacco Company of India Limited
  • Itaconix
  • Japan Tobacco Inc.
  • Johnson & Johnson
  • JUUL Labs, Inc.
  • Novartis International AG
  • Perrigo Company PLC
  • Pfizer Inc.
  • Philip Morris International Inc.
  • Pierre Fabre S.A.
  • Rusan Pharma Ltd.
  • Samyang Holdings Corporation
  • Sparsha Pharma International Pvt. Ltd.
  • Strides Pharma Science Limited

Methodology

Loading
LOADING...

Related Topics

Related Reports

Smoking Cessation And Nicotine De-addiction Market Size, Share & Trends Analysis Report By Type (Nicotine Replacement Therapy), By Form, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Smoking Cessation And Nicotine De-addiction Market Size, Share & Trends Analysis Report By Type (Nicotine Replacement Therapy), By Form, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Smoking Cessation and Nicotine De-Addiction Products Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Smoking Cessation and Nicotine De-Addiction Products Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Smoking Cessation and Nicotine De-Addiction Products - Global Strategic Business Report - Product Image

Smoking Cessation and Nicotine De-Addiction Products - Global Strategic Business Report

  • Report
  • 114 Pages
  • Global
From
Smoking Cessation and Nicotine De-Addiction Products Market Report 2025 - Product Image

Smoking Cessation and Nicotine De-Addiction Products Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Smoking Cessation and Nicotine De-addiction Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Smoking Cessation and Nicotine De-addiction Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.